The first evidence of IL-21 antitumor activity in vivo was shown in a murine model, when colon carcinoma cells transduced to express IL-21 were rejected, the antitumor effects being dependent on T and NK cells, in this case (53). Here, IL21 is linked to colon carcinoma.